# Exome Asset Management LLC: Form 13F holdings

An institutional investment manager in NEW YORK, NY. SEC CIK 2011932.

- Quarter ended: 2026-06-30
- Filed: 2026-08-14
- Reported value: $162.1m
- Positions: 52 (52 lines in the filing's table; lines for the same security and option type are added together here)
- Compared with: the 13F for the quarter ended 2026-03-31
- Filing: https://www.sec.gov/Archives/edgar/data/2011932/000142050626001714/

## Holdings

As filed, largest first. Reported value is what the manager stated at the quarter end (Jun 30, 2026), in US dollars; it is filing data, not a price. Weight is the share of the total reported value.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [GUARDANT HEALTH INC (GH)](/companies/gh.md) | COM | $10.1m | 6.2% | 67,500 |  | Reduced −15,236 |
| [PRAXIS PRECISION MEDICINES I (PRAX)](/companies/prax.md) | COM NEW | $9.1m | 5.6% | 27,205 |  | Reduced −18,264 |
| [TG THERAPEUTICS INC (TGTX)](/companies/tgtx.md) | COM | $9.1m | 5.6% | 164,915 |  | New +164,915 |
| [COGENT BIOSCIENCES INC (COGT)](/companies/cogt.md) | COM | $8.1m | 5.0% | 210,523 |  | Reduced −68,010 |
| [IONIS PHARMACEUTICALS INC (IONS)](/companies/ions.md) | COM | $7.0m | 4.3% | 88,177 |  | Reduced −21,887 |
| [ELI LILLY & CO (LLY)](/companies/lly.md) | COM | $6.6m | 4.1% | 5,492 |  | Reduced −1,520 |
| [ABIVAX SA (ABVX)](/companies/abvx.md) | SPONSORED ADS | $6.2m | 3.9% | 46,878 |  | New +46,878 |
| [ALUMIS INC (ALMS)](/companies/alms.md) | COM | $5.8m | 3.5% | 204,418 |  | Reduced −74,758 |
| [CYTOKINETICS INC (CYTK)](/companies/cytk.md) | COM NEW | $5.1m | 3.2% | 60,056 |  | Reduced −43,662 |
| [ENLIVEN THERAPEUTICS INC (ELVN)](/companies/elvn.md) | COM | $5.1m | 3.1% | 100,203 |  | Reduced −119,888 |
| [VERA THERAPEUTICS INC (VERA)](/companies/vera.md) | CL A | $4.2m | 2.6% | 97,276 |  | Reduced −17,715 |
| [UNITEDHEALTH GROUP INC (UNH)](/companies/unh.md) | COM | $4.0m | 2.5% | 9,612 |  | Reduced −3,250 |
| [10X GENOMICS INC (TXG)](/companies/txg.md) | CL A COM | $3.9m | 2.4% | 102,629 |  | Reduced −51,565 |
| [NATERA INC (NTRA)](/companies/ntra.md) | COM | $3.7m | 2.3% | 13,800 |  | Reduced −4,850 |
| UNIQURE NV | SHS | $3.7m | 2.3% | 81,056 |  | New +81,056 |
| [RHYTHM PHARMACEUTICALS INC (RYTM)](/companies/rytm.md) | COM | $3.6m | 2.2% | 32,209 |  | Reduced −8,372 |
| [MAZE THERAPEUTICS INC (MAZE)](/companies/maze.md) | COM | $3.4m | 2.1% | 114,692 |  | Added +26,182 |
| [MONTE ROSA THERAPEUTICS INC (GLUE)](/companies/glue.md) | COM | $3.3m | 2.0% | 137,115 |  | Reduced −42,369 |
| [MOONLAKE IMMUNOTHERAPEUTICS (MLTX)](/companies/mltx.md) | CLASS A ORD | $3.2m | 2.0% | 166,493 |  | Reduced −48,883 |
| ALKERMES PLC | SHS | $3.2m | 2.0% | 61,336 |  | Reduced −22,767 |
| [LIQUIDIA CORPORATION (LQDA)](/companies/lqda.md) | COM NEW | $3.1m | 1.9% | 39,224 |  | Reduced −6,572 |
| [UNITED THERAPEUTICS CORP DEL (UTHR)](/companies/uthr.md) | COM | $2.9m | 1.8% | 5,410 |  | Reduced −1,643 |
| [GLAUKOS CORP (GKOS)](/companies/gkos.md) | COM | $2.8m | 1.7% | 19,862 |  | Reduced −1,012 |
| [ARROWHEAD PHARMACEUTICALS IN (ARWR)](/companies/arwr.md) | COM | $2.6m | 1.6% | 32,214 |  | Reduced −13,507 |
| [AGIOS PHARMACEUTICALS INC (AGIO)](/companies/agio.md) | COM | $2.6m | 1.6% | 70,500 |  | Reduced −54,560 |
| CRESCENT BIOPHARMA INC. | COM | $2.3m | 1.4% | 127,769 |  | Reduced −25,422 |
| ASTRAZENECA PLC | ORD | $2.3m | 1.4% | 12,045 |  | New +12,045 |
| [BOSTON SCIENTIFIC CORP (BSX)](/companies/bsx.md) | COM | $2.1m | 1.3% | 48,347 |  | Unchanged |
| [ADAGENE INC (ADAG)](/companies/adag.md) | ADS | $2.1m | 1.3% | 488,293 |  | Reduced −248,552 |
| [PENUMBRA INC (PEN)](/companies/pen.md) | COM | $2.0m | 1.2% | 6,300 |  | Unchanged |
| [INTUITIVE SURGICAL INC (ISRG)](/companies/isrg.md) | COM NEW | $2.0m | 1.2% | 4,908 |  | Reduced −1,450 |
| [VIKING THERAPEUTICS INC (VKTX)](/companies/vktx.md) | COM | $1.9m | 1.2% | 47,861 |  | New +47,861 |
| [OCULAR THERAPEUTIX INC (OCUL)](/companies/ocul.md) | COM | $1.8m | 1.1% | 181,588 |  | New +181,588 |
| [EQUILLIUM INC (EQ)](/companies/eq.md) | COM | $1.8m | 1.1% | 552,956 |  | New +552,956 |
| ASCENDIS PHARMA A/S | ORD SHS | $1.8m | 1.1% | 6,573 |  | New +6,573 |
| [CORBUS PHARMACEUTICALS HLDGS (CRBP)](/companies/crbp.md) | COM NEW | $1.7m | 1.1% | 184,914 |  | Reduced −49,222 |
| [CYTOMX THERAPEUTICS INC. (CTMX)](/companies/ctmx.md) | COM | $1.7m | 1.1% | 460,067 |  | Reduced −61,401 |
| [VERASTEM INC (VSTM)](/companies/vstm.md) | COM NEW | $1.6m | 1.0% | 429,041 |  | Reduced −207,659 |
| [NEKTAR THERAPEUTICS (NKTR)](/companies/nktr.md) | COM NEW | $1.6m | 1.0% | 22,417 |  | New +22,417 |
| [CLEARPOINT NEURO INC (CLPT)](/companies/clpt.md) | COM | $1.5m | 0.9% | 83,636 |  | New +83,636 |
| [INSMED INC (INSM)](/companies/insm.md) | COM PAR $.01 | $1.5m | 0.9% | 13,873 |  | Reduced −12,778 |
| [CARIS LIFE SCIENCES INC (CAI)](/companies/cai.md) | COM | $1.4m | 0.9% | 78,180 |  | New +78,180 |
| [BRIDGEBIO PHARMA INC (BBIO)](/companies/bbio.md) | COM | $1.4m | 0.8% | 18,359 |  | Reduced −49,133 |
| [ZENAS BIOPHARMA INC (ZBIO)](/companies/zbio.md) | COM | $1.3m | 0.8% | 52,443 |  | Reduced −28,287 |
| [NOVABRIDGE BIOSCIENCES (NBP)](/companies/nbp.md) | SPONSORED ADS | $1.1m | 0.7% | 576,960 |  | Unchanged |
| ESTABLISHMENT LABS HLDGS INC | COM | $1.1m | 0.7% | 13,100 |  | Unchanged |
| [RELAY THERAPEUTICS INC (RLAY)](/companies/rlay.md) | COM | $889.3k | 0.5% | 47,531 |  | Reduced −230,771 |
| [GERON CORP (GERN)](/companies/gern.md) | COM | $798.8k | 0.5% | 624,046 |  | New +624,046 |
| [BRIGHT MINDS BIOSCIENCES INC (DRUG)](/companies/drug.md) | COM NEW | $709.7k | 0.4% | 10,110 |  | New +10,110 |
| [COMPASS THERAPEUTICS INC (CMPX)](/companies/cmpx.md) | COM | $604.8k | 0.4% | 276,165 |  | New +276,165 |
| [REPLIMUNE GROUP INC (REPL)](/companies/repl.md) | COM | $446.8k | 0.3% | 40,361 |  | New +40,361 |
| [ARBUTUS BIOPHARMA CORP (ABUS)](/companies/abus.md) | COM | $240.8k | 0.1% | 50,166 |  | Reduced −25,318 |

## Sold out

Held at the end of the quarter before and not reported this quarter.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [4D MOLECULAR THERAPEUTICS IN (FDMT)](/companies/fdmt.md) | COM | $0 | 0.0% | 0 |  | Sold out −130,564 |
| ALUMIS INC | PUT | $0 | 0.0% | 0 | Put | Sold out −105,000 |
| APELLIS PHARMACEUTICALS INC | COM | $0 | 0.0% | 0 |  | Sold out −85,517 |
| [AVALO THERAPEUTICS INC (AVTX)](/companies/avtx.md) | COM NEW | $0 | 0.0% | 0 |  | Sold out −159,341 |
| BEONE MEDICINES LTD | CALL | $0 | 0.0% | 0 | Call | Sold out −10,000 |
| CENTESSA PHARMACEUTICALS PLC | PUT | $0 | 0.0% | 0 | Put | Sold out −34,700 |
| COMPASS THERAPEUTICS INC | CALL | $0 | 0.0% | 0 | Call | Sold out −25,100 |
| CYTOKINETICS INC | PUT | $0 | 0.0% | 0 | Put | Sold out −60,000 |
| [ELEVANCE HEALTH INC FORMERLY (ELV)](/companies/elv.md) | COM | $0 | 0.0% | 0 |  | Sold out −14,677 |
| IDEAYA BIOSCIENCES INC | CALL | $0 | 0.0% | 0 | Put | Sold out −40,000 |
| IDEAYA BIOSCIENCES INC | CALL | $0 | 0.0% | 0 | Call | Sold out −40,000 |
| [LIPOCINE INC NEW (LPCN)](/companies/lpcn.md) | COM NEW | $0 | 0.0% | 0 |  | Sold out −60,861 |
| LIQUIDIA CORPORATION | PUT | $0 | 0.0% | 0 | Put | Sold out −40,000 |
| [NEXTCURE INC (NXTC)](/companies/nxtc.md) | COM NEW | $0 | 0.0% | 0 |  | Sold out −115,500 |
| [PALISADE BIO INC (PALI)](/companies/pali.md) | COM | $0 | 0.0% | 0 |  | Sold out −600,000 |
| SOLENO THERAPEUTICS INC | COM | $0 | 0.0% | 0 |  | Sold out −61,673 |
| SPDR SERIES TRUST | STATE STREET SPD | $0 | 0.0% | 0 | Put | Sold out −60,000 |
| TRAVERE THERAPEUTICS INC | PUT | $0 | 0.0% | 0 | Put | Sold out −20,000 |
| WAVE LIFE SCIENCES LTD | PUT | $0 | 0.0% | 0 | Put | Sold out −30,000 |

Source: SEC EDGAR, Form 13F-HR, accession 0001420506-26-001714. Last ingested by Listed: Oct 22, 2026, 05:26 ET. No prices; not investment advice.